Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Mark_Kotter
|
| gptkbp:developedBy |
cell therapies
human cell models |
| gptkbp:focusesOn |
synthetic biology
cell reprogramming stem cell technology |
| gptkbp:foundedBy |
gptkb:Mark_Kotter
|
| gptkbp:foundedIn |
2016
|
| gptkbp:fundedBy |
gptkb:Foresite_Capital
gptkb:Arch_Venture_Partners gptkb:Tencent gptkb:National_Horizons_Centre gptkb:Charles_River_Laboratories |
| gptkbp:headquartersLocation |
gptkb:Cambridge,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Bit Bio
|
| gptkbp:mission |
to code cells for health
|
| gptkbp:notableProduct |
gptkb:ioCells
|
| gptkbp:website |
https://www.bit.bio/
|
| gptkbp:bfsParent |
gptkb:Wellcome_Trust_Sanger_Institute
|
| gptkbp:bfsLayer |
5
|